Advertisement

Product › Details
immunotherapy
![]() |
Next higher product group | pharmaceutical |
Record changed: 2024-09-20 |
Advertisement

More documents for immunotherapy
- [1] Normunity, Inc.. (1/13/25). "Press Release: Normunity Closes $75 million Series B Financing to Advance Lead Drug Program into the Clinic and Broaden Pipeline of Novel Anti-cancer Therapies Targeting Untapped Drug Mechanisms". Boston, MA & New Haven, CT....
- [2] Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried....
- [3] BioCopy AG. (10/17/23). "Press Release: BioCopy and Yumab Announce Partnership for Development of Innovative safeTY-engager Platform". Emmendingen & Braunschweig....
- [4] Immatics N.V.. (9/11/23). "Press Release: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics". Cambridge, MA & Tübingen....
- [5] BiondVax Pharmaceuticals Ltd.. (8/11/23). "Press Release: BiondVax Reports Second Quarter Financial Results and Provides Business Update". Jerusalem....
- [6] BiondVax Pharmaceuticals Ltd.. (8/1/23). "Press Release: Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules". Jerusalem....
- [7] Friedrich-Alexander-Universität Erlangen-Nürnberg. (2/20/23). "Press Release: Testing Their Strength –CAR T-cells Combat Muscle Inflammation. Universitätsklinikum Erlangen the First in the World to Use a Pioneering New Method to Successfully Treat a ...
- [8] Technische Universität München. (11/28/22). "Press Release: Nanoswitches for Tumor Targeting. TUM Spin-off Plectonic Develops Antibody-based Immunotherapies"....
- [9] Affimed N.V.. (11/3/22). "Press Release: Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101". Heidelberg & San Diego, CA....
- [10] Immunic, Inc.. (10/10/22). "Press Release: Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing". New York, NY....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top